236 related articles for article (PubMed ID: 31954756)
1. The GLP-1 receptor agonist liraglutide reverses mania-like alterations and memory deficits induced by D-amphetamine and augments lithium effects in mice: Relevance for bipolar disorder.
Chaves Filho AJM; Cunha NL; de Souza AG; Soares MV; Jucá PM; de Queiroz T; Oliveira JVS; Valvassori SS; Barichello T; Quevedo J; de Lucena D; Macedo DS
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109872. PubMed ID: 31954756
[TBL] [Abstract][Full Text] [Related]
2. Effects of alpha-lipoic acid in an animal model of mania induced by D-amphetamine.
Macêdo DS; Medeiros CD; Cordeiro RC; Sousa FC; Santos JV; Morais TA; Hyphantis TN; McIntyre RS; Quevedo J; Carvalho AF
Bipolar Disord; 2012 Nov; 14(7):707-18. PubMed ID: 22897629
[TBL] [Abstract][Full Text] [Related]
3. Antimanic-like activity of candesartan in mice: Possible involvement of antioxidant, anti-inflammatory and neurotrophic mechanisms.
de Souza Gomes JA; de Souza GC; Berk M; Cavalcante LM; de Sousa FC; Budni J; de Lucena DF; Quevedo J; Carvalho AF; Macêdo D
Eur Neuropsychopharmacol; 2015 Nov; 25(11):2086-97. PubMed ID: 26321203
[TBL] [Abstract][Full Text] [Related]
4. Doxycycline reverses cognitive impairment, neuroinflammation and oxidative imbalance induced by D-amphetamine mania model in mice: A promising drug repurposing for bipolar disorder treatment?
Chaves Filho AJM; Cunha NL; Rodrigues PA; de Souza AG; Soares MV; Jucá PM; de Queiroz T; Clemente DCDS; Mottin M; Andrade CH; Peixoto CA; Macedo DS
Eur Neuropsychopharmacol; 2021 Jan; 42():57-74. PubMed ID: 33191076
[TBL] [Abstract][Full Text] [Related]
5. Prevention of pentylenetetrazole-induced kindling and behavioral comorbidities in mice by levetiracetam combined with the GLP-1 agonist liraglutide: Involvement of brain antioxidant and BDNF upregulating properties.
de Souza AG; Chaves Filho AJM; Souza Oliveira JV; de Souza DAA; Lopes IS; de Carvalho MAJ; de Lima KA; Florenço Sousa FC; Mendes Vasconcelos SM; Macedo D; de França Fonteles MM
Biomed Pharmacother; 2019 Jan; 109():429-439. PubMed ID: 30399578
[TBL] [Abstract][Full Text] [Related]
6. Effects of lithium on oxidative stress and behavioral alterations induced by lisdexamfetamine dimesylate: relevance as an animal model of mania.
Macêdo DS; de Lucena DF; Queiroz AI; Cordeiro RC; Araújo MM; Sousa FC; Vasconcelos SM; Hyphantis TN; Quevedo J; McIntyre RS; Carvalho AF
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():230-7. PubMed ID: 23333378
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of folic acid as an adjunct to lithium therapy on manic-like behaviors, oxidative stress and inflammatory parameters in an animal model of mania.
Menegas S; Dal-Pont GC; Cararo JH; Varela RB; Aguiar-Geraldo JM; Possamai-Della T; Andersen ML; Quevedo J; Valvassori SS
Metab Brain Dis; 2020 Feb; 35(2):413-425. PubMed ID: 31840201
[TBL] [Abstract][Full Text] [Related]
8. Coadministration of lithium and celecoxib reverses manic-like behavior and decreases oxidative stress in a dopaminergic model of mania induced in rats.
Valvassori SS; Tonin PT; Dal-Pont GC; Varela RB; Cararo JH; Garcia AF; Gava FF; Menegas S; Soares JC; Quevedo J
Transl Psychiatry; 2019 Nov; 9(1):297. PubMed ID: 31723123
[TBL] [Abstract][Full Text] [Related]
9. Coadministration of lithium and celecoxib attenuates the behavioral alterations and inflammatory processes induced by amphetamine in an animal model of mania.
Valvassori SS; Dal-Pont GC; Tonin PT; Varela RB; Ferreira CL; Gava FF; Andersen ML; Soares JC; Quevedo J
Pharmacol Biochem Behav; 2019 Aug; 183():56-63. PubMed ID: 31158395
[TBL] [Abstract][Full Text] [Related]
10. Doxycycline reversal of amphetamine-induced mania-like behavior is related to adjusting brain monoamine abnormalities and antioxidant effects in primary hippocampal neurons.
Chaves-Filho AJM; Soares MV; Jucá PM; Oliveira TQ; Clemente DCDS; Monteiro CEDS; Silva FGO; de Aquino PEA; Macedo DS
Naunyn Schmiedebergs Arch Pharmacol; 2024 Feb; ():. PubMed ID: 38386042
[TBL] [Abstract][Full Text] [Related]
11. Lithium modulates the production of peripheral and cerebral cytokines in an animal model of mania induced by dextroamphetamine.
Valvassori SS; Tonin PT; Varela RB; Carvalho AF; Mariot E; Amboni RT; Bianchini G; Andersen ML; Quevedo J
Bipolar Disord; 2015 Aug; 17(5):507-17. PubMed ID: 25929806
[TBL] [Abstract][Full Text] [Related]
12. Antimanic activity of minocycline in a GBR12909-induced model of mania in mice: Possible role of antioxidant and neurotrophic mechanisms.
de Queiroz AIG; Chaves Filho AJM; Araújo TDS; Lima CNC; Machado MJS; Carvalho AF; Vasconcelos SMM; de Lucena DF; Quevedo J; Macedo D
J Affect Disord; 2018 Jan; 225():40-51. PubMed ID: 28783519
[TBL] [Abstract][Full Text] [Related]
13. The role of neurotrophic factors in manic-, anxious- and depressive-like behaviors induced by amphetamine sensitization: Implications to the animal model of bipolar disorder.
Valvassori SS; Mariot E; Varela RB; Bavaresco DV; Dal-Pont GC; Ferreira CL; Andersen ML; Tye SJ; Quevedo J
J Affect Disord; 2019 Feb; 245():1106-1113. PubMed ID: 30699853
[TBL] [Abstract][Full Text] [Related]
14. Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania.
Frey BN; Andreazza AC; Ceresér KM; Martins MR; Valvassori SS; Réus GZ; Quevedo J; Kapczinski F
Life Sci; 2006 Jun; 79(3):281-6. PubMed ID: 16460767
[TBL] [Abstract][Full Text] [Related]
15. Effects of lithium and valproate on ERK/JNK signaling pathway in an animal model of mania induced by amphetamine.
Valvassori SS; Gava FF; Dal-Pont GC; Simões HL; Damiani-Neves M; Andersen ML; Boeck CR; Quevedo J
Heliyon; 2019 May; 5(5):e01541. PubMed ID: 31193305
[TBL] [Abstract][Full Text] [Related]
16. Lithium and tamoxifen modulate cellular plasticity cascades in animal model of mania.
Cechinel-Recco K; Valvassori SS; Varela RB; Resende WR; Arent CO; Vitto MF; Luz G; de Souza CT; Quevedo J
J Psychopharmacol; 2012 Dec; 26(12):1594-604. PubMed ID: 23076832
[TBL] [Abstract][Full Text] [Related]
17. Indoleamine-2,3-dioxygenase-1 is a molecular target for the protective activity of mood stabilizers against mania-like behavior induced by d-amphetamine.
Tran HQ; Shin EJ; Saito K; Tran TV; Phan DH; Sharma N; Kim DW; Choi SY; Jeong JH; Jang CG; Cheong JH; Nabeshima T; Kim HC
Food Chem Toxicol; 2020 Feb; 136():110986. PubMed ID: 31760073
[TBL] [Abstract][Full Text] [Related]
18. Effects of cannabidiol on amphetamine-induced oxidative stress generation in an animal model of mania.
Valvassori SS; Elias G; de Souza B; Petronilho F; Dal-Pizzol F; Kapczinski F; Trzesniak C; Tumas V; Dursun S; Chagas MH; Hallak JE; Zuardi AW; Quevedo J; Crippa JA
J Psychopharmacol; 2011 Feb; 25(2):274-80. PubMed ID: 19939866
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase activity and brain-derived neurotrophic factor (BDNF) levels in a pharmacological model of mania.
Stertz L; Fries GR; Aguiar BW; Pfaffenseller B; Valvassori SS; Gubert C; Ferreira CL; Moretti M; Ceresér KM; Kauer-Sant'Anna M
Braz J Psychiatry; 2014; 36(1):39-46. PubMed ID: 24346357
[TBL] [Abstract][Full Text] [Related]
20. Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania.
Frey BN; Valvassori SS; Réus GZ; Martins MR; Petronilho FC; Bardini K; Dal-Pizzol F; Kapczinski F; Quevedo J
J Psychiatry Neurosci; 2006 Sep; 31(5):326-32. PubMed ID: 16951735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
